Skip to main navigation
Company Logo
  • About
    • About Overview
    • Leadership
    • Careers
  • Product
    • RECELL® System
  • Clinical Development
    • Pipeline/Clinical Trials
    • Patient Outcomes
    • Proof Assets
  • News & Media
  • Investor Relations
    • Overview
    • Press Releases
    • Events & Presentations
    • Financials
    • Annual Reports & Proxy
    • Stock Information
    • Corporate Governance
    • FAQ
    • Email Alerts
    • Contact
  • Contact
  • Search
  • Overview
  • Press Releases
  • Events & Presentations
  • Financials
  • Annual Reports & Proxy
  • Stock Information
  • Corporate Governance
  • FAQ
  • Email Alerts
  • Contact
/press-releases/news-releases
global

Investors: Press Releases

AVITA Medical to Present at the Piper Sandler 35th Annual Healthcare Conference
November 21, 2023
Learn More
AVITA Medical Updates Full Year 2023 Guidance
November 20, 2023
Learn More
AVITA Medical Reports Third Quarter Financial Results with 51% Revenue Growth over the Same Period the Prior Year
November 9, 2023
Learn More
  • News Releases
  • Announcements
November 21, 2023
AVITA Medical to Present at the Piper Sandler 35th Annual Healthcare Conference
November 20, 2023
AVITA Medical Updates Full Year 2023 Guidance
November 9, 2023
AVITA Medical Reports Third Quarter Financial Results with 51% Revenue Growth over the Same Period the Prior Year
November 9, 2023
AVITA Medical Announces Distribution Partnership with PolyMedics Innovations to Expand to Europe
October 19, 2023
AVITA Medical to Announce Third Quarter 2023 Financial Results
October 18, 2023
AVITA Medical Announces Preliminary Third Quarter 2023 Financial Highlights and Secures up to $90 million of Non-Dilutive Debt Financing with OrbiMed to Support Growth Initiatives
September 25, 2023
AVITA Medical Receives Best Product Award at the American Association for the Surgery of Trauma
September 21, 2023
AVITA Medical to Present at the Cantor Global Healthcare Conference
September 6, 2023
AVITA Medical to Participate in Upcoming Investor Conferences
August 14, 2023
AVITA Medical to Host Investor Webinar Briefing
August 10, 2023
AVITA Medical Reports Second Quarter Financial Results
July 20, 2023
AVITA Medical to Announce Second Quarter 2023 Financial Results
June 29, 2023
AVITA Medical Submits FDA PMA Supplement for RECELL GO
June 26, 2023
AVITA Medical Rejoins the Russell 3000 Index
June 16, 2023
AVITA Medical Announces FDA Approval of RECELL for Skin Repigmentation in Vitiligo Patients
June 15, 2023
AVITA Medical Announces Appointment of David O’Toole as Chief Financial Officer
June 7, 2023
AVITA Medical Announces FDA Approval of RECELL for Treatment of Full-Thickness Skin Defects
May 15, 2023
AVITA Medical to Host Investor Webinar Briefing
May 11, 2023
AVITA Medical Reports First Quarter Financial Results and Affirms Full Year Guidance
April 20, 2023
AVITA Medical to Announce First Quarter 2023 Financial Results
Pagination
  • Current page 1
  • Page 2
  • Next page ›
  • Last page »
AVITA Medical, Inc. Logo with tag

Contact Investor Relations

Jessica Ekeberg
Director, Investor Relations
investor@avitamedical.com

Request Email Alerts
® 2023 AVITA Medical, Inc.
  • Terms of Use
  • Privacy Policy
  • CA Compliance
  • Social Media
  • CCPA
  • Compliance and Ethics
  • Important Safety Information

Social Media

  • Twitter (opens in new window)
  • Linkedin (opens in new window)